Seven questions. A clear picture of where your biomarker strategy stands relative to your development phase, and what to do next.

Below is an example of the outcome presented in a radar chart. Each question represents a critical function that should be part of your biomarker strategy. Your answers are compared to the expected level of progression for a given phase of drug development. The graph indicates strengths, where you are ahead of schedule, or weaknesses that need more attention. 
The questionnaire presented here is a quick scan, aimed to provide an overview within a minute. If you want more depth, I can review your plans in full and help you close the gaps. See below for the extended virtual 360 biomarker advisory board.